{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:42:05Z","timestamp":1779907325908,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T00:00:00Z","timestamp":1313539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00417-011-1769-7","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T13:51:17Z","timestamp":1313589077000},"page":"1795-1803","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and histopathological features and immunoreactivity of human choroidal and ciliary melanomas as prognostic factors for metastasis and death"],"prefix":"10.1007","volume":"249","author":[{"given":"Camila C.","family":"Sim\u00f5es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy K.","family":"Call","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z\u00e9lia M.","family":"Corr\u00eaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbot G.","family":"Spaulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Augsburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,17]]},"reference":[{"issue":"3","key":"1769_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(96)80024-5","volume":"41","author":"CM Mooy","year":"1996","unstructured":"Mooy CM, De Jong PT (1996) Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 41(3):215\u2013228","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"1769_CR2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh AD, Topham A (2003) Incidence of uveal melanoma in the United States: 1973\u20131997. Ophthalmology 110(5):956\u2013961","journal-title":"Ophthalmology"},{"issue":"11","key":"1769_CR3","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivel\u00e4 T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44(11):4651\u20134659","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1769_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/01658100701473275","volume":"14","author":"MM Gilson","year":"2007","unstructured":"Gilson MM, Diener-West M, Hawkins BS (2007) Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. COMS report number 24. Ophthalmic Epidemiol 14(4):251\u20137","journal-title":"Ophthalmic Epidemiol"},{"key":"1769_CR5","first-page":"131","volume":"36","author":"GR Callender","year":"1931","unstructured":"Callender GR (1931) Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36:131\u2013142","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"issue":"11","key":"1769_CR6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/0046-8177(92)90299-I","volume":"23","author":"R Folberg","year":"1992","unstructured":"Folberg R, Pe\u2019er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC (1992) The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 23(11):1298\u20131305","journal-title":"Hum Pathol"},{"issue":"9","key":"1769_CR7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-6420(93)31470-3","volume":"100","author":"R Folberg","year":"1993","unstructured":"Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe\u2019er J, Gruman LM (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100(9):1389\u20131398","journal-title":"Ophthalmology"},{"issue":"5","key":"1769_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0161-6420(97)30234-6","volume":"104","author":"IW McLean","year":"1997","unstructured":"McLean IW, Keefe KS, Burnier MN (1997) Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumor size. Ophthalmology 104(5):777\u2013780","journal-title":"Ophthalmology"},{"issue":"4","key":"1769_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/91.4.359","volume":"91","author":"T Makitie","year":"1999","unstructured":"Makitie T, Summanen P, Tarkannen A, Kivel\u00e4 T (1999) Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Natl Cancer Inst 91(4):359\u2013367","journal-title":"J Natl Cancer Inst"},{"key":"1769_CR10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"G Prescher","year":"1996","unstructured":"Prescher G, Bornfeld N, Hirche H, Horsthemke B, J\u00f6ckel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347:1222\u20131225","journal-title":"Lancet"},{"issue":"1","key":"1769_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2","volume":"19","author":"K Sisley","year":"1997","unstructured":"Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC (1997) Abnormalities of chromosome 3 and 8 in posterior uveal melanoma correlate with prognosis. Gene Chromosomes Cancer 19(1):22\u201328","journal-title":"Gene Chromosomes Cancer"},{"issue":"2","key":"1769_CR12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R","volume":"83","author":"VA White","year":"1998","unstructured":"White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE (1998) Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83(2):354\u2013359","journal-title":"Cancer"},{"issue":"3","key":"1769_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1088>3.0.CO;2-7","volume":"30","author":"NC Naus","year":"2001","unstructured":"Naus NC, Van Drunen E, de Klein A, Luyten GP, Paridaens DA, Alers JC, Ksander BR, Beverloo HB, Slater RM (2001) Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karotyping, and comparative genomic hybridization. Genes Chromosomes Cancer 30(3):267\u2013273","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"1769_CR14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1167\/iovs.02-0159","volume":"44","author":"AG Scholes","year":"2003","unstructured":"Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK (2003) Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 44(3):1008\u20131011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"1769_CR15","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205\u20137209","journal-title":"Cancer Res"},{"issue":"5","key":"1769_CR16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1158\/1078-0432.CCR-06-2401","volume":"13","author":"LA Worley","year":"2007","unstructured":"Worley LA, Onken MD, Person E, Robirds D, Branson J, Char DH, Perry A, Harbour JW (2007) Transcriptonic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 13(5):1466\u20131471","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1769_CR17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1167\/iovs.05-0422","volume":"47","author":"SS Kadkol","year":"2006","unstructured":"Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe\u2019er J (2006) Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest Ophthalmol Vis Sci 47(3):802\u2013806","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1769_CR18","first-page":"169","volume":"141","author":"U Fuchs","year":"1992","unstructured":"Fuchs U, Kivel\u00e4 T, Summanen P, Immonen I, Tarkkanen A (1992) An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol 141(1):169\u2013181","journal-title":"Am J Pathol"},{"issue":"2","key":"1769_CR19","first-page":"153","volume":"78","author":"MJ Hendrix","year":"1998","unstructured":"Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M, Pe\u2019er J, Folberg R (1998) Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Invest 78(2):153\u2013163","journal-title":"Lab Invest"},{"issue":"3","key":"1769_CR20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1015591624171","volume":"19","author":"EA Seftor","year":"2002","unstructured":"Seftor EA, Meltzer PS, Kirschmann DA, Pe\u2019er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJ (2002) Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19(3):233\u2013246","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"1769_CR21","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-07-5144","volume":"14","author":"MD Onken","year":"2008","unstructured":"Onken MD, Worley LA, Harbour JW (2008) A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 14(12):3737\u20133745","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1769_CR22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","volume":"18","author":"SH Chang","year":"2008","unstructured":"Chang SH, Worley LA, Onken MD, Harbour JW (2008) Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 18(3):191\u2013200","journal-title":"Melanoma Res"},{"issue":"1","key":"1769_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2009.01.023","volume":"148","author":"JJ Augsburger","year":"2009","unstructured":"Augsburger JJ, Corr\u00eaa ZM, Shaikh AH (2009) Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 148(1):119\u2013127","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1769_CR24","first-page":"179","volume":"26","author":"T Standal","year":"2004","unstructured":"Standal T, Borset M, Sundan A (2004) Role of Osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26(3):179\u2013184","journal-title":"Exp Oncol"},{"issue":"5","key":"1769_CR25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.0022-202X.2005.23680.x","volume":"124","author":"YW Zhou","year":"2005","unstructured":"Zhou YW, Dai DL, Martinka M et al (2005) Osteopontin expression correlates with melanoma invasion. J Invest Dermatol 124(5):1044\u20131052","journal-title":"J Invest Dermatol"},{"issue":"10","key":"1769_CR26","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/sj.bjc.6601839","volume":"90","author":"SR Rittling","year":"2004","unstructured":"Rittling SR, Chambers AF (2004) Role of osteopontin in tumour progression. Br J Cancer 90(10):1877\u20131881","journal-title":"Br J Cancer"},{"issue":"4A","key":"1769_CR27","first-page":"1897","volume":"27","author":"V Barak","year":"2007","unstructured":"Barak V, Frenkel S, Kalickman I et al (2007) Serum markers to detect metastatic uveal melanoma. Anticancer Res 27(4A):1897\u20131900","journal-title":"Anticancer Res"},{"issue":"4","key":"1769_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000206139","volume":"223","author":"I Haritoglou","year":"2009","unstructured":"Haritoglou I, Wolf A, Maier T, Haritoglou C, Hein R, Schaller UC (2009) Osteopontin and melanoma inhibitory activity: comparison of two serological tumor markers in metastatic uveal melanoma patients. Ophthalmologica 223(4):239\u2013243","journal-title":"Ophthalmologica"},{"issue":"8","key":"1769_CR29","first-page":"1492","volume":"31","author":"J Kan-Mitchell","year":"1990","unstructured":"Kan-Mitchell J, Rao N, Albert DM, Van Eldik LJ, Taylor CR (1990) S100 immunophenotypes of uveal melanomas. Invest Ophthalmol Vis Sci 31(8):1492\u20131496","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1769_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00627007","volume":"400","author":"J Caselitz","year":"1983","unstructured":"Caselitz J, J\u00e4nner M, Breitbart E, Weber K, Osborn M (1983) Malignant melanomas contain only the vimentin type of intermediate filaments. Virchows Arch A Pathol Anat Histopathol 400(1):43\u201351","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"3","key":"1769_CR31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI110810","volume":"71","author":"FC Ramaekers","year":"1983","unstructured":"Ramaekers FC, Puts JJ, Moesker O, Kant A, Vooijs GP, Jap PH (1983) Intermediate filaments in malignant melanoma. Identification and use in surgical pathology. J Clin Invest 71(3):635\u2013643","journal-title":"J Clin Invest"},{"issue":"6","key":"1769_CR32","first-page":"623","volume":"61","author":"M Miettinen","year":"1989","unstructured":"Miettinen M, Franssila K (1989) Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab Invest 61(6):623\u2013628","journal-title":"Lab Invest"},{"key":"1769_CR33","unstructured":"Pitz S, Moll R, Rochels R (1989) Intermediate filaments and melanoma markers in ocular malignant melanomas. An immunohistochemical and biochemical study. Abstracts of the International Symposium, Tumors of the Eye, Deutsche Ophthalmologische Gesellschaft, Essen, Germany, p23"},{"issue":"7","key":"1769_CR34","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1073\/pnas.96.7.3928","volume":"96","author":"H Ishii","year":"1999","unstructured":"Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H, Mori M, Fidanza V, Alder H, Croce CM (1999) The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci USA 96(7):3928\u20133933","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"1769_CR35","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1073\/pnas.181222898","volume":"98","author":"H Ishii","year":"2001","unstructured":"Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, Alder H, Baffa R, Croce CM (2001) FEZ1\/LTZS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis. Proc Natl Acad Sci USA 98(18):10374\u201310379","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1769_CR36","first-page":"1546","volume":"7","author":"A Vecchione","year":"2001","unstructured":"Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, Murakumo Y, Alder H, Croce CM, Baffa R (2001) FEZ1\/LZTS1 alterations in gastric carcinoma. Clin Cancer Res 7(6):1546\u20131552","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1769_CR37","first-page":"297","volume":"23","author":"K Ono","year":"2003","unstructured":"Ono K, Uzawa K, Nakatsuru M, Shiiba M, Mochida Y, Tada A, Bukawa H, Miyakawa A, Yokoe H, Tanzawa H (2003) Downregulation of FEZ1\/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinoma. Int J Oncol 23(2):297\u2013302","journal-title":"Int J Oncol"},{"key":"1769_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1747-1028-2-24","volume":"2","author":"A Vecchione","year":"2007","unstructured":"Vecchione A, Croce CM, Baldassarre G (2007) FEZ1\/LZTS1 a new mitotic regulator implicated in cancer development. Cell Div 2:24","journal-title":"Cell Div"},{"issue":"6","key":"1769_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/CMR.0b013e3282f1d302","volume":"17","author":"W Zuidervaart","year":"2007","unstructured":"Zuidervaart W, Pavey S, Van Nieuwpoort FA et al (2007) Expression of Wnt5a and its downstream effector \u03b2-catenin in uveal melanoma. Melanoma Res 17(6):380\u2013386","journal-title":"Melanoma Res"},{"issue":"4","key":"1769_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K","volume":"186","author":"R Silye","year":"1998","unstructured":"Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M (1998) E-cadherin\/catenin complex in benign and malignant melanocytic lesions. J Pathol 186(4):350\u2013355","journal-title":"J Pathol"},{"issue":"5","key":"1769_CR41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.10893","volume":"103","author":"E Kielhorn","year":"2003","unstructured":"Kielhorn E, Provost E, Olsen D, D\u2019Aquila TG, Smith BL, Camp RL, Rimm DL (2003) Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 103(5):652\u2013656","journal-title":"Int J Cancer"},{"issue":"10","key":"1769_CR42","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1091\/mbc.11.10.3509","volume":"11","author":"K Kim","year":"2000","unstructured":"Kim K, Pang KM, Evans M, Hay ED (2000) Overexpression of \u03b2-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol Biol Cell 11(10):3509\u20133523","journal-title":"Mol Biol Cell"},{"issue":"9","key":"1769_CR43","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1158\/0008-5472.CAN-05-4196","volume":"66","author":"MD Onken","year":"2006","unstructured":"Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, Harbour JW (2006) Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 66(9):4602\u20134609","journal-title":"Cancer Res"},{"issue":"1","key":"1769_CR44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/excr.1998.4238","volume":"245","author":"K Kim","year":"1998","unstructured":"Kim K, Kj D, Hay ED (1998) Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Exp Cell Res 245(1):79\u201390","journal-title":"Exp Cell Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1769-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1769-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1769-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:48:10Z","timestamp":1559058490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1769-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,17]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1769-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,17]]}}}